The Journal of Immunology, Vol 147, Issue 2 698-704, Copyright © 1991 by American Association of Immunologists

ARTICLES

Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells

N Terada, JJ Lucas and EW Gelfand
Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.

We have activated resting human T lymphocytes to study the roles of the putative cell cycle control gene products, retinoblastoma susceptibility gene product (Rb) and p53, in regulating cell proliferation. After stimulation with phorbol, 12,13, dibutyrate and the calcium ionophore, ionomycin, which triggers a rapid entry of cells into G1 phase, we demonstrated Rb phosphorylation 24 h later, well before the onset of DNA synthesis. This finding, in contrast to reports using proliferating cell lines, implies that Rb phosphorylation is not a proximal event regulating the G1 to S transition. The production of p53 became detectable 3 to 6 h after addition of phorbol, 12,13,- dibutyrate and ionomycin, and peaked at 30 to 42 h. To further delineate the relationship of the synthesis and metabolism of the proteins to cell cycle progression, we used three agents to arrest progression of activated T cells at various points in the cell cycle. Aphidicolin arrested the cells at the G1/S boundary, whereas deferoxamine, an iron chelator, arrested the cells at an earlier stage of the cell cycle. Cyclosporin A blocked T cell activation at the earliest point in the cell cycle. In the presence of aphidicolin, Rb phosphorylation and p53 production proceeded normally whereas cyclosporin A inhibited both events. Although deferoxamine completely prevented Rb phosphorylation, p53 production was unaffected, suggesting a differential regulation of the two molecules. Our results place Rb phosphorylation and p53 production in the hierarchy of genetic events that are thought to regulate T lymphocyte progression through the cell cycle.

This article has been cited by other articles:

				D. Szuts and T. Krude Cell cycle arrest at the initiation step of human chromosomal DNA replication causes DNA damage J. Cell Sci., October 1, 2004; 117(21): 4897 - 4908. [Abstract] [Full Text] [PDF]

				N. T.V. Le and D. R. Richardson Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1, but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation Carcinogenesis, June 1, 2003; 24(6): 1045 - 1058. [Abstract] [Full Text] [PDF]

				J. Hernandez, A. Ko, and L. A. Sherman CTLA-4 Blockade Enhances the CTL Responses to the p53 Self-Tumor Antigen J. Immunol., March 15, 2001; 166(6): 3908 - 3914. [Abstract] [Full Text] [PDF]

				D. H. Dreyfus, M. Nagasawa, C. A. Kelleher, and E. W. Gelfand Stable expression of Epstein-Barr virus BZLF-1-encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells Blood, July 15, 2000; 96(2): 625 - 634. [Abstract] [Full Text] [PDF]

				J. Hernandez, P. P. Lee, M. M. Davis, and L. A. Sherman The Use of HLA A2.1/p53 Peptide Tetramers to Visualize the Impact of Self Tolerance on the TCR Repertoire J. Immunol., January 15, 2000; 164(2): 596 - 602. [Abstract] [Full Text] [PDF]

				K. M. van der Meulen, H. J. Nauwynck, W. Buddaert, and M. B. Pensaert Replication of equine herpesvirus type 1 in freshly isolated equine peripheral blood mononuclear cells and changes in susceptibility following mitogen stimulation J. Gen. Virol., January 1, 2000; 81(1): 21 - 25. [Abstract] [Full Text]

				P. J. Papst, H. Sugiyama, M. Nagasawa, J. J. Lucas, J. L. Maller, and N. Terada Cdc2-Cyclin B Phosphorylates p70 S6 Kinase on Ser411 at Mitosis J. Biol. Chem., June 12, 1998; 273(24): 15077 - 15084. [Abstract] [Full Text] [PDF]

				D. J. Morgan, H. T. C. Kreuwel, S. Fleck, H. I. Levitsky, D. M. Pardoll, and L. A. Sherman Activation of Low Avidity CTL Specific for a Self Epitope Results in Tumor Rejection But Not Autoimmunity J. Immunol., January 15, 1998; 160(2): 643 - 651. [Abstract] [Full Text] [PDF]

				M. Theobald, J. Biggs, J. Hernandez, J. Lustgarten, C. Labadie, and L. A. Sherman Tolerance to p53 by A2.1-restricted Cytotoxic T Lymphocytes J. Exp. Med., March 3, 1997; 185(5): 833 - 842. [Abstract] [Full Text] [PDF]

				A Ferreira and K. Kosik Accelerated neuronal differentiation induced by p53 suppression J. Cell Sci., January 6, 1996; 109(6): 1509 - 1516. [Abstract] [PDF]